Open Access. Powered by Scholars. Published by Universities.®
Articles 1 - 1 of 1
Full-Text Articles in Medicine and Health Sciences
Ototoxic Hearing Loss And Retinoblastoma Patients, Shaum Bhagat
Ototoxic Hearing Loss And Retinoblastoma Patients, Shaum Bhagat
Faculty Publications
Chemotherapy is often used in the conservative management of retinoblastoma. Chemotherapy drugs, while ameliorative, can produce long-lasting side effects that potentially can affect survivor quality of life. Carboplatin is a common chemotherapy agent with known ototoxic side effects that is used in the treatment of retinoblastoma (Rodriguez-Galindo et al., 2003). The potential for carboplatin-induced hearing loss is of concern to the medical professional, given that retinoblastoma is often diagnosed in early childhood and children with retinoblastoma have visual impairments. This chapter will outline the mechanisms underlying carboplatin ototoxicity. The extent of knowledge concerning the pathophysiology of carboplatin-induced hearing loss will …